At synapses throughout the mammalian brain, AMPA receptors form complexes with auxiliary 15 proteins, including TARPs. However, how TARPs modulate AMPA receptor gating remains poorly 16 understood. We built structural models of TARP-AMPA receptor complexes for TARPs γ2 and γ8, 17 combining recent structural studies and de novo structure predictions. These models, combined 18 with peptide binding assays, provide evidence for multiple interactions between GluA2 and variable 19 extracellular loops of TARPs. Substitutions and deletions of these loops had surprisingly rich 20 effects on the kinetics of glutamate-activated currents, without any effect on assembly. Critically, by 21 altering the two interacting loops of γ2 and γ8, we could entirely remove all allosteric modulation of 22 GluA2, without affecting formation of AMPA receptor-TARP complexes. Likewise, substitutions in 23 the linker domains of GluA2 completely removed any effect of TARPs on receptor kinetics, 24 indicating a dominant role for this previously overlooked site proximal to the AMPA receptor 25 channel gate. 26 3 of 38 Introduction 27
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To understand the scope of TARP interactions with the AMPA receptor, we began by modeling the 84 loops of γ2 and γ8 into a hybrid structure composed of Claudins and GluA2. Comparing these 85 hybrid complexes to CryoEM electron density maps suggested that a range of interaction sites with receptors by particular allosteric modulators that bind at the dimer interface (36, 37) . We reasoned 95 that extracellular loop interactions that stabilized the superactive state could preferentially target 96 the GluA2 LBD dimer. To test this hypothesis, we composed an overlapping library of hexameric 97 peptides based on extracellular sections of TARPs, targeting the long loop 1 of γ2 and γ8, and 98 other potential interacting sites (Figure 1 -Figure supplement 1C ). Because the active dimer of 99 LBDs ought to be intact for superactivation, we compared the interactions of our peptide library 100 between the GluA2 LBD (flip form) and LBDs harboring the L483Y substitution, which greatly 8 of 38 had steady-state current of 50 ± 5 % (n = 30; Figures 2A and D and Table 1 ), twice as large as γ2 140 alone (25 ± 2 %, n = 24 patches), and the rate of entry to desensitization was approximately halved 141 (35 ± 5 s -1 , n = 30; Figure 2C and Table 1 ). In contrast, the γ8 chimera with L1 from γ2 maintained 142 143 Figure 2. Desensitization properties of γ2 and γ8 L1 mutants. A) Representative traces from L1 γ8 in γ2 (red) and L1 γ2 in γ8 (blue) coexpressed with GluA2 in response to a 500 ms pulse of 10 mM Glutamate (k des = 13 and 55 s -1 ; I ss = 50 and 30 %, respectively). Example traces recorded from the parent TARPs coexpressed with GluA2 are shown in grey for comparison (k des = 41 and 30 s -1 ; I ss = 30 and 30 %, for γ2 and γ8, respectively). B)
Representative traces from γ2 ∆L1 (red) and γ8 ∆L1 (blue) coexpressed with GluA2 in response to a 500 ms pulse of 10 mM Glutamate (k des = 55 and 45 s -1 ; I ss = 10 and 15 %, respectively). The wild type constructs coexpressed with GluA2 are shown as dashed lines for comparison. C) Bar graph summarizing the effects of the L1 mutation on the desensitization kinetics. D) Bar graph summarizing the effects of the loop1 mutations on the steady state current of the complexes. Currents were recorded at +50 mV in the presence of 50 µM spermine in the pipette solution. For panels C and D, Filled symbols correspond to the traces shown in A) and B). ***p < 0.001, ** p < 0.01, against γ2; ∆ p < 0.05, ∆∆ p < 0.01, against γ8. Source data for panels C & D is found in 
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Seeking a further explanation for the modulation of desensitization by TARPs, we investigated the 153 effects of altering the 8-residue stretch in the second extracellular segment of TARPs (L2), which 154 connects TM3 to β5 in the extracellular domain. Replacement of the L2 segment with a flexible 155 Gly-Ser linker, predicted to be of sufficient length not to disrupt the overall structure of the 156 extracellular domain, had a striking effect on γ2. The rate of entry to desensitization was still slower 157 than in receptors formed of GluA2 wild type (WT) alone (65 ± 5 s -1 and 120 ± 15 s -1 , n = 15 and 9 158 patches for A2 + γ2 L2_GS and A2 WT, respectively; Figures 3A and C and Table 1 ), but the 159 steady state current was reduced to the level of receptors without any TARP present (5 ± 1 % and 160 5 ± 1 %, n = 15 and 9 for A2 + γ2 L2_GS and A2 WT, respectively; Figures 3A and D and Table 1 ).
161
In contrast, there was no detectable effect on γ8 of mutating this loop, except for a further slowing 162 down of the desensitization rate (k des = 25 ± 5 s -1 , I ss = 40 ± 4%, n = 6 , for γ8 L2_GS; Figures 3A,
163
C and D and Table 1 ).
165
Even more striking were results of coexpression of a chimera of γ2 with the GS-linker replacing L2, 166 but harboring the long L1 loop of γ8. This chimera massively slowed entry to desensitization, 167 producing complexes about 10-fold slower than receptors without any TARP (k des = 10 ± 0. γ2 in γ8, with the GS-linker replacing L2) effectively nullified the modulatory activity of γ8. Table 1 ) was closer to that of wild-type GluA2 than for the γ2 L2_GS 175 chimera (see Table 1 ). 
Figures 3B and C and
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Although we performed all measurements at +50 mV, isolating heavily TARPed receptors by 177 selecting for complexes with strong relief of polyamine block, we were concerned that some of the 178 effects that we saw (particularly reduced or absent modulation) could be due to an altered 179 stoichiometry of complexes, perhaps due to poor chimera expression. To assess this possibility,
180
we measured the G-V relations for all the chimeras and deletion mutants (Figure 2 - Figure   181 supplement 1). Importantly, all mutants gave responses that were strongly reduced in rectification,
182
indicating that complex formation was normal. Broadly, each chimera closely followed the TARPs induce a subtype-specific superactivation of the GluA2 homomeric receptor. γ8 is a much 189 stronger modifier of this slow gating mode than γ2 (36, 37). We investigated the role of the 190 extracellular domain in superactivation using the same set of TARP mutants, but using 7-second 191 applications of glutamate to measure the equilibrium level reached following superactivation. Our 192 hypothesis was that the difference in superactivation between γ2 and γ8 would be specified by the 193 sequence element most divergent between these two TARPs, L1.
195
In the chimeras swapping loop 1 between γ8 and γ2, the results were asymmetric ( Figure 4) 
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Given the residual superactivation that we saw in the absence of loop 1, we reasoned that loop 2 206 could play a role in receptor superactivation ( Figure 5 ). We measured responses to 10 mM 207 glutamate for the L2_GS mutants of γ2 and γ8 and found substantially reduced superactivation 208 (1.3 ± 0.6 and 12 ± 2 %, n = 8 and 4, respectively; Table 1 ).
210
Even more strikingly, the same TARP mutants with loop 1 swapped had a further reduced effect.
211
The loop 1 from γ2 in the L2_GS mutant of γ8 had almost negligible superactivation, reduced by 212 ~15-fold from wild-type γ8, to about 1 ± 0.7 % (n = 6; Figures 5B and C and Table 1 ). Taking into 213 account the lack of steady-state current, fast desensitization and similar deactivation kinetics to 
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wild-type GluA2 alone that we observed in patches containing complexes of GluA2 with the L1 γ2 215 in γ8 L2_GS mutant, we classed this chimera as a kinetic null of γ8.
217
The TARP chimeras that exhibited the least power to slow desensitization kinetics and to stabilize 218 active states were those that replaced charged residues in the L2 segment, and from which we 219 either deleted L1, or included the short loop from γ2. These observations guided our construction 220 of a kinetically-null γ2. We reasoned that a γ2 chimera lacking L1 and with a GS-linker replacing L2 Table 1 ). Somewhat surprisingly, the deletion of L1 from γ8 on the L2-GS background retained a 227 larger steady state current than the chimera that included the L1 segment of γ2 (I ss = 5 ± 1% and 228 10 ± 5 %, n = 6 and 5, for L1 γ2 in γ8 L2_GS and γ8 ΔL1 L2_GS, respectively; Figures 5B and C,
229
6E and G and Table 1 ) and a small superactivation (3 ± 1 %, n = 4; Figure 6A and Table 1 ).
231
L2 controls gating through interaction with linkers proximal to the channel gate 232 From our models, a range of sites on GluA2 could interact with L1, including the KGK motif in the 233 LBD (30, 38) . Substitutions at L2 of γ2 and γ8 had profound effects on gating of TARP complexes 234 and are well placed to interact with gating machinery ( Figure 1A and S1B). Particularly, we 235 expected from our structural models and other available structural data (34, 35) that L2 should 236 interact with the S1-M1 linker and the S2-M4 linker in the AMPA receptor. The L2 sequence has an 237 alternating charge motif that is mirrored in two parts of the GluA2 linkers 508-510 and 781-783.
238
These segments are immediately adjacent to the TARP L2 in all four subunits. 
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Replacement of 508QKS510 to GAG in the S1-M1 linker (GluA2 508GAG510, Figure 7A Figure 7E and Table 1 ). Our model suggested that the S2-M4 248 linker of GluA2 was equally well positioned to interact with L2 from γ2. To test the importance of 249 the alternating charges in the S2-M4 linker, we made another triple mutation replacing 781KEK783 250 to GSG (GluA2 781GSG783, Figure 7B ). This mutant again had normal kinetics in the absence of Table 1 ). Importantly, the combination of these two triple mutants, 
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To discern whether the loss of modulation occurred because the linker sites are the primary 261 interaction site, or whether the linkers both interact with TARPs and transmit upstream modulation 262 from sites in the LBD, we assessed modulation by γ8 and related chimeras. The propensity of γ8 263 to modulate gating of the double linker mutant (GluA2 GAG/GSG) was reduced, but robust 264 superactivation could still be observed (25 ± 5%, n = 5, Figure 7 and Table 1) . Given this result, 265 which suggested that L1 could still modulate gating of complexes, we hypothesized that the γ2 266 chimera incorporating the L1 of γ8 should also modulate the double linker mutant. This chimera 267 could not produce superactivating complexes (2 ± 2 %, n = 4, Figures 7D and E , as for the γ2 18 of 38 chimera lacking L2 interactions, L1 γ8 in γ2 L2_GS, Figure 5A ) but retained the slow desensitizing 270 behavior due to L1 (k des = 12 ± 0.5, n = 5, Figure 7E and Table 1 ).
272
In coherence with our previous results, mutation of the GluA2 linkers ablated the effect of the γ8 273 chimera with L1 from γ2 to modulate the kinetics of complexes, reducing the steady state current 274 and superactivation to the same levels as GluA2 wild-type in the absence of TARP (I ss = 4 ± 1 %, 275 superactivation = 1 ± 1 %, n = 5 and 4, Figure 7E and Table 1 ). Therefore, in the absence of the 276 long L1, γ8 fails to modulate GluA2 when the S1-M1 and S2-M4 linker interaction sites are 277 removed (again consistent with its cousin lacking L2 interaction sites, the L1 γ2 in γ8 L2_GS 278 variant; see Figure 5C ).
280
Overall, these results indicate that the long loop of γ8 L1 is still able to modulate complexes at 281 extracellular sites with the receptor linker sites disrupted, supporting the idea that the linkers do not 282 function primarily to transduce distant TARP modulation. Rather, the LBD-TMD linkers are the 283 primary modulatory site for both γ8 and γ2. The latter has a short L1 loop, and cannot modulate 284 receptors if the L2 interaction is absent. However, γ8 combines the longer L1 and the L2 site to 285 modulate receptor properties more effectively, in a compound fashion.
287
Discussion
288
The results we present here offer several new insights into TARP function. First of all, extracellular 289 sites account for all the modification of AMPA receptor gating by TARPs. Previous work showed 290 that L1 could transfer aspects of modulation between TARPs, but our experiments indicate that the 291 2nd short extracellular segment (L2), which varies strongly in sequence between TARPs, is 292 dominant. Further work will be required to establish the generality of this modulatory mechanism.
294
Secondly, these same sites do not have any appreciable role in determining assembly of TARP-295 AMPA receptor complexes. Intuitively, this division of roles makes sense because gating 296 modification requires transient interactions on a timescale far faster than receptor assembly.
297
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Therefore, interactions between transmembrane segments and intracellular regions are 298 responsible for assembly and modulation of polyamine block.
300
Thirdly, we show that the linkers to the transmembrane domain are key sites for modulation of 301 AMPA receptor gating by auxiliary proteins, and provide insights into the molecular basis of this 302 interaction. Previous work suggested ATD interactions and prominent roles for the LBD in 303 modulation, but the interactions we demonstrate here are much more proximal to the channel gate 304 (25). We could show a very close functional confluence between modifying the receptor itself and 
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Fourth, we show that the long extracellular loop 1 of γ8 is a very strong positive modulator of 320 AMPA receptor gating, whose influence is likely held in check by the substoichiometric combination (Figures 1 and S1 ). Whilst this problem could be due 336 to deficits in our model, another explanation is that the linkers (S1-M1 and S2-M4) are disrupted 337 from their basal positions, and that the L2 loop can wedge between them. Upon activation, it is 338 expected that the linkers will move away from the overall pore axis, which could permit further 339 state-dependent interactions (See cartoon in Figure 8C ).
341
Future structural studies may permit a more detailed view into the interactions between L2 and the 342 linker domains of AMPAR. Although Claudin structures allowed positioning of auxiliary proteins 343 with high confidence within CryoEM reconstructions, the loops that we have investigated here are 344 not resolved within these structures, possibly because they interact transiently and are otherwise 345 disordered. Although our peptide array suggested that stretches of L1 interact with the LBD, we 346 were not able to obtain co-crystal structures of peptides with monomeric or dimeric forms of the 347 GluA2 LBD. Nonetheless, knowledge of Claudin structures enabled us to make structurally 348 sympathetic substitutions into TARPs for functional experiments that did not disrupt expression or 
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Because our observations suggest that the AMPA receptor linkers are key to TARP modulation, it 362 is likely that chimeric receptors with altered linkers that exhibit constitutive gating are bad reporters 363 of the TARP-GluA modulation, although they clearly delineate assembly motifs (29). The molecular 364 nature of the interactions we have identified here raise the intriguing possibility that acute 365 disassembly of complexes, rather than modulation, might be the target of recent subtype specific 366 drugs (19, 20) .
368
Our results allow us to construct a tentative model for the distinct forms of modulation that TARPs 369 produce ( Figure 8C ). The slow increase in glutamate efficacy, which we term superactivation, is 370 specified by the combination of L1 and L2, whereas the basal increase in steady state current 371 arises from L2 alone. We previously modeled the modulatory interaction between TARPs and the 372 AMPA receptor with single conformational change, but did not consider desensitization. The 373 concerted involvement of multiple loops suggests multiple conformational states are required to 374 describe the interaction, most notably in the case of γ8. The greater conformational space that can 375 be explored by loop 1, and its strong connection to superactivation, indicate that these 376 conformational changes could relate to the slow transitions represented in the model of 377 superactivation (37). In contrast, conformational changes of the linker region of the AMPA receptor 378 upon opening will naturally lead to a state-dependent interaction with L2 of γ2 or γ8, because of 379 the direct proximity. A further level of complexity is that an intact L2 segment is required for the 380 strong superactivation induced by γ8, but is not required at all for slow desensitization behavior 381 that the long L1 loop of γ8 can produce. Because in these experiments, slow desensitization 382 23 of 38 occurs when occupancy of superactive states is low, we can quite reasonably assume that L1 383 adopts multiple conformations to stabilize separate functional states of the receptor, and that some 384 functional signatures require a concerted action of both loops. Additional stabilization of 385 desensitized states by the variable loop 1 is also likely (30).
387
This work has produced mutant TARPs and AMPA receptors that both lack modulatory properties, 388 and also those that have greatly enhanced modulation. Both these signatures of activity should be 389 useful tools for investigating TARP action in synapses, including understanding the relative 390 importance of assembly into complexes for anchoring (39) as opposed to kinetic modulation, for 391 clarifying the consequences of TARP modulation for short term plasticity (18), and for better 392 identifying TARPs in ternary complexes with other auxiliary subunits (17, 40) .
Materials and Methods
394
Molecular biology
395
We used GluA2 flip receptors, unedited at the pore site (Q-containing) in the pRK vector also 396 expressing eGFP following an internal ribosomal entry site (IRES) sequence. Mouse γ2 was the 397 kind gift of Susumu Tomita and was expressed from an IRES-dsRed construct as previously 398 described (37). Mouse γ8 (the kind gift of Roger Nicoll) was expressed the same way. Point Wild type or mutant GluA2 and TARP constructs were co-transfected in HEK 293 cells with PEI.
406
The ratios of co-transfection were 1:2 for GluA2-γ2 and 1:5 for GluA2-γ8, up to 2 μg total DNA per 407 35 mm dish. The same ratios were maintained for all the reciprocal mutants. Cells were 408 supplemented with 40 μM NBQX to reduce TARP-induced cytotoxicity. Recordings were performed 409 24-48 hours after transfection. The external recording solution contained (in mM): 150 NaCl, 0.1 410 MgCl 2 , 0.1 CaCl 2 and 5 HEPES, titrated to pH 7.3 with NaOH. The pipette solution contained (in 411 mM): 120 NaCl, 10 NaF, 0.5 CaCl 2 , 5 Na 4 BAPTA, 5 HEPES and 0.05 spermine, pH 7.3. 10 mM 412 glutamate was applied to outside-out patches with a piezo-driven fast perfusion system (PI,
413
Germany). In order to isolate currents exclusively mediated by TARPed receptors, patches were 414 voltage-clamped at a holding potential of +50 mV. Currents were low-pass filtered at 5 kHz using 
418
Data analysis. To measure receptor desensitization we applied 10 mM glutamate for 500 419 ms. Desensitization rate and steady-state current were then obtained by fitting the traces with a 420 sum of two, and when necessary three, exponentials. Rates constants are expressed as weighted 25 of 38 mean of multiple components. Superactivation was measured during a 7 second application of 422 glutamate and was defined as the excess steady-state amplitude following the desensitization 423 trough, normalized to the peak current. A triple exponential function was used to fit the slowly 424 augmenting current of superactivation measurements. To account for possible variability in the 425 response and expression of the complexes, we tried to record at least 5-6 patches from at least 426 three different transfections for each condition. For experiments with very low success rates (that 427 is, worse than 1 patch in 20 giving an acceptable recording), in the presence of γ8, at least three 428 patches were collected. No data were excluded, except from patches where recordings were 429 unstable, had excessive rundown or solution exchange slower than 0.5 ms as measured after the 430 experiment. Results are shown as mean ± standard error of the mean (s.e.m.) and statistical 431 significance was assessed with a two-tailed Student's t-test as specified in Table 1 . peptides shifted by one residue. Peptide spotted membranes were rinsed with ethanol for 5 449 minutes, following three times 10 min washing with TBS and incubation with blocking buffer 450 (Casein Blocking buffer (Sigma B6429), 150 mM Saccharose, in TBS) for 3 hours at RT. The 451 blocking buffer was removed by three wash steps with TBS before the membranes were incubated 452 overnight at 4°C with either 50 µg/ml protein (GluA2_LBD or GluA2_LBD_LY) in blocking buffer or 453 blocking buffer only for control. Membranes were washed three times in TBS and incubated for 1.5 454 hours at RT with anti-poly_His Antibody (Sigma H1029) diluted 1:6000 in blocking solution followed 455 by three washes (a' 10 min) with TBS. Finally, membranes were incubated for 1.5 hours at RT with 456 HRP-conjugated anti-mouse IgG Antibody (Sigma A5906; 1:1000 dilution in blocking buffer) and 457 washed with TBS (three times a' 10 min). Visualization of protein-binding was carried out using a 458 chemo-luminescence substrate (Pierce™ ECL, ThermoFisher Scientific) and a Lumi-Imager TM 459 instrument (Boehringer Mannheim, Germany). Spot-signal intensities were measured in Boehringer
460
Light Units (BLU) and the software GeneSpotter 2.6.0 (MicroDiscovery, Berlin, Germany) was 461 applied for data processing. Hits from peptides located within β-sheets were taken to be false 462 positives, because when isolated these peptides likely form unphysiological β-sheets in a non-463 specific manner with existing structures in the GluA2 LBD. To have an idea about reproducibility of 464 this assay, we performed it twice with comparable results (source data is provided). The negative 465 control showed no signal, indicating no unspecific binding of the anti-poly His to the peptides.
467
Structural modeling 468 Initial γ2 and γ8 models were generated based on the crystal structure of claudin15 (PDB code: connecting linkers (S1-TM1 and S2-TM4) are not resolved in the AMPA-TARP cryo-EM structure.
477
To better understand the Loop 2 participation in AMPA receptor regulation we used the crystal 478 structure of GluA2 (PDB code: 3kg2) with resolved linkers and superposed it onto the receptor of 479 our AMPA-TARP complex model (Figure 1 -Figure supplement 2) . As the side chains of the 480 possible interacting residues (507-QKS-510, 781KSK-783) located in the LBD-TMD linkers were 481 not resolved in 3kg2 we modeled the most likely side chain conformations of these residues 482 ( Figures 7A and B) . All figures were prepared with PyMOL or IGOR Pro. 
